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Abstract
 
Bartonella henselae
 
 causes vasculoproliferative disorders in humans. We identified a nonfimbrial
adhesin of 
 
B. henselae
 
 designated as 
 
Bartonella
 
 adhesin A (BadA). BadA is a 340-kD outer membrane
protein encoded by the 9.3-kb 
 
badA
 
 gene. It has a modular structure and contains domains ho-
mologous to the 
 
Yersinia enterocolitica
 
 nonfimbrial adhesin (
 
Yersinia
 
 adhesin A). Expression of
BadA was restored in a BadA-deficient transposon mutant by complementation in trans. BadA
mediates the binding of 
 
B. henselae
 
 to extracellular matrix proteins and to endothelial cells, possi-
bly via 
 
 
 
1 integrins, but prevents phagocytosis. Expression of BadA is crucial for activation of
hypoxia-inducible factor 1 in host cells by 
 
B. henselae
 
 and secretion of proangiogenic cytokines
(e.g., vascular endothelial growth factor). BadA is immunodominant in 
 
B. henselae
 
–infected patients
and rodents, indicating that it is expressed during 
 
Bartonella
 
 infections. Our results suggest that
BadA, the largest characterized bacterial protein thus far, is a major pathogenicity factor of 
 
B.
henselae
 
 with a potential role in the induction of vasculoproliferative disorders.
Key words: pilus • endothelial cells • HIF-1 • VEGF • angiogenesis
 
Introduction
 
Bartonella henselae
 
 is a facultative intracellular bacterium
causing cat scratch disease (CSD), bacillary angiomatosis
(BA), and bacillary peliosis (BP; reference 1). CSD is a self-
limiting disease characterized by lymphadenopathy related
to a cat scratch. In immunocompromised individuals, 
 
B.
henselae
 
 causes tumorous proliferations of endothelial cells
(ECs) in the skin and internal organs, referred to as BA and
BP, respectively (2-4).
Stimulation of angiogenesis upon a 
 
Bartonella
 
 infection rep-
resents one fascinating feature of human pathogenic bacteria.
 
Bartonella
 
 species may cause these vasculoproliferations by at
least three different mechanisms that may act synergistically:
(a) triggering EC proliferation directly (5), (b) inhibition of
apoptosis of ECs (6), and (c) induction of the secretion of vas-
culoproliferative cytokines (e.g., vasculoendothelial growth
factor [VEGF]; references 7 and 8). In vivo and in vitro infec-
tion with 
 
B. henselae
 
 results in the activation of hypoxia-
inducible factor (HIF)-1 (unpublished data), the key tran-
scription factor of angiogenesis (9). The proliferating ECs are
one potential habitat of 
 
B. henselae
 
, as the pathogen survives
and replicates within these cells in vitro (10, 11).
Only few bacterial factors operating in 
 
Bartonella
 
–host
cell interactions are known. One of the most important
putative pathogenicity factors of 
 
B. henselae
 
 is the “type IV
pilus” (12), which mediates host cell adhesion and trigger-
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Abbreviations used in this paper:
 
 ADM, adrenomedullin; BA, bacillary angi-
omatosis; BadA, 
 
Bartonella
 
 adhesin A; BP, bacillary peliosis; CBA, Columbia
blood agar; CLSM, confocal laser scanning microscopy; CSD, cat scratch
disease; EC, endothelial cell; ECM, extracellular matrix; Fn, fibronectin;
HIF, hypoxia-inducible factor; HMW, high molecular weight; IEM, immu-
noelectronmicroscopy; IGFBP-3, insulin-like growth factor binding pro-
tein 3; NadA, 
 
Neisseria
 
 adhesin A; OMP, outer membrane protein; PFA,
paraformaldehyde; TEM, transmission electron microscopy; VEGF, vas-
culoendothelial growth factor; YadA, 
 
Yersinia
 
 adhesin A. 
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ing of VEGF secretion (7). “Pilus” expression undergoes
phase variation with multiple passages on agar plates (12).
Additional candidates in 
 
Bartonella
 
 pathogenicity are outer
membrane proteins (OMPs; references 13 and 14) and the
 
virB 
 
type IV secretion system that is responsible for the in-
hibition of apoptosis in ECs (15).
Many pathogenic bacteria assemble multifunctional pro-
teinaceous surface structures that serve as adhesins. Such
nonfimbrial adhesins, e.g., 
 
Yersinia
 
 adhesin A (YadA) of en-
teropathogenic 
 
Yersinia
 
 species and 
 
Neisseria
 
 adhesin A
(NadA) of 
 
Neisseria meningitidis
 
, have been described as a
novel class of bacterial adhesins representing important
pathogenicity factors (16, 17). YadA, the best investigated
representative of this protein family, mediates adherence to
host cells (18) and extracellular matrix (ECM) proteins
(19). YadA expression is essential for pathogenicity of 
 
Yers-
inia enterocolitica
 
 in a murine infection model (20). Accord-
ingly, NadA is crucial for establishing 
 
N. meningitidis
 
 infec-
tion in an infant rat model (17).
Here, we describe the identification, cloning, and charac-
terization of 
 
Bartonella
 
 adhesin A (BadA), formerly known as
“type IV pili.” The 340-kD BadA protein, encoded by the
9.3-kb 
 
badA
 
 gene, is located in the outer membrane of 
 
B.
henselae
 
. BadA is constructed modularly and contains do-
mains homologous to 
 
Y. enterocolitica
 
 YadA. BadA mediates
the binding of 
 
B. henselae
 
 to ECM proteins and ECs, and
prevents phagocytosis. It is also crucial for activation of HIF-1
and secretion of VEGF. Moreover, we provide evidence
that BadA is expressed during 
 
Bartonella
 
 infections in humans
and rodents with implications for serodiagnosis of 
 
Bartonella
 
infections. Our results suggest that BadA is a major pathoge-
nicity factor of 
 
B. henselae
 
 with a potential role in the induc-
tion of the vasculoproliferative disorders BA and BP.
 
Materials and Methods
 
Bacteria and Growth Conditions.
 
Bacteria are summarized in
Table I. 
 
B. henselae
 
 was grown on Columbia blood agar (CBA) in
a humidified atmosphere at 37
 
 
 
C and 5% CO
 
2
 
. 
 
Escherichia coli
 
 was
grown in Luria-Bertani broth. Antibiotics were used at the fol-
lowing concentrations: 
 
B. henselae
 
: 30 
 
 
 
g/ml kanamycin, 1 
 
 
 
g/
ml chloramphenicol; 
 
E. coli
 
: 50 
 
 
 
g/ml kanamycin, 50 
 
 
 
g/ml
chloramphenicol, 100 
 
 
 
g/ml ampicillin.
For production of bacterial stock suspensions, bacteria were
harvested from agar plates after 5 d and frozen in Luria-Bertani–
20% glycerol at 
 
 
 
80
 
 
 
C. The pilus-negative variant strain (
 
B.
henselae
 
 Pil
 
 
 
) was produced by extensively passaging 
 
B. henselae
 
Marseille WT (7).
 
SDS-PAGE and Immunoblotting. B. henselae
 
 were resuspended
in SDS sample buffer and heated at 98
 
 
 
C for 3 min. SDS-PAGE
was performed in 12% gels. Gels were stained with Coomassie
Blue R250. For immunoblotting, proteins were transferred onto
nitrocellulose membranes (Schleicher and Schuell). Blots were
blocked for 1 h in 5% skim milk powder in 25 mM Tris, pH 7.5,
0.15 M NaCl, and 0.05% Tween 20 (Sigma-Aldrich), and incu-
bated with the respective primary antibody overnight. For detec-
tion, a horseradish peroxidase–conjugated secondary antibody
was used and signals were visualized either via chemilumines-
cence (Amersham Biosciences) or with DAB (3,3
 
 
 
-diaminoben-
zidine tetrahydrochloride; Sigma-Aldrich).
A BadA-specific rabbit antiserum was raised by immunization
with a BadA stalk fragment (badA-f6-badA-r6; Table II) and puri-
fied by affinity chromatography, a rabbit anti–
 
B. henselae
 
 Marseille
serum was raised by immunization with viable bacteria (11), and a
mouse anti–
 
B. henselae
 
 Marseille serum was raised by immuniza-
tion with heat-killed bacteria. Human sera were obtained from
patients with the clinical diagnosis of CSD and immunoreactivity
of 
 
 
 
1:200 in an immunofluorescence test according to the rec-
ommendations of the Centers of Disease Control (21).
 
Protein Identification. B. henselae
 
 was lysed in 7 M urea, 2 M
thiourea, and 4% 3-[(3-cholamidopropyl)dimethylammonio]-1-
propanesulfonate, and centrifuged at 100,000 
 
g
 
 for 1 h at 4
 
 
 
C.
SDS-PAGE was followed by matrix-assisted laser desorption/
ionization peptide mass fingerprinting and electrospray ionization
tandem mass spectrometry. In-gel digestion and protein identifi-
cation with H
 
2
18
 
O method was performed as described previ-
ously (22). After ZipTip purification (C18-ZipTip; Millipore),
aliquots were deposited on 
 
 
 
-cyano-4-hydroxycinnamic acid-
nitrocellulose for matrix-assisted laser desorption/ionization-time
of flight mass analysis (Reflex III; Bruker Daltonic). All measure-
ments were performed in the positive ion reflection mode at an
accelerating voltage of 23 kV and delayed-pulsed ion extraction.
Sequence verification was performed by nanoelectrospray tandem
mass spectrometry on a hybrid quadrupole orthogonal accelera-
 
Table I.
 
Bacterial Strains Used in This Study
 
Strain Characteristics
Reference or
source
 
B. henselae
 
Wild-type (WT)
 
B. henselae
 
 Marseille, patient isolate, early passage 4
Pil
 
  
 
variant
 
B. henselae
 
 Marseille, extensively passaged, pilus-negative 7
BadA
 
 
 
B. henselae
 
 Marseille TN <KAN-2> transposon mutant, transposon integrated in 
 
badA
 
This study
BadA
 
 
 
/BadA
 
  
 
WT
 
B. henselae
 
 BadA2
 
    
 
complemented with pTR15 This study
Houston-1 ATCC 49882 published genome sequence (NC_005956) 24
 
E. coli
 
TOP 10 host strain used for cloning Invitrogen
DH5
 
 
 
host strain used for cloning Invitrogen
BL21 (DE3) host strain used for protein expression Stratagene 
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tion time of flight mass spectrometer (QSTAR Pulsar i; Applied
Biosystems). N- versus COOH-terminal peptide sequence orien-
tation was determined using 
 
18
 
O labeling of the COOH termini.
MASCOT database searches (National Center for Biotechnology
Information [NCBI] nonredundant protein database) used methi-
onine oxidations as variable modifications.
 
DNA Techniques.
 
Plasmids and primers are listed in Table
II. DNA manipulations were performed according to standard
protocols.
 
Transposon Mutagenesis.
 
Transposon mutagenesis was per-
formed by electroporation of the EZ::TN 
 
 
 
KAN-2
 
 
 
 transpo-
son (EZ::TN 
 
 
 
KAN-2
 
 
 
 Tnp Transposome Kit; Epicentre) as
described previously (23).
 
Cloning of badA.
 
For construction of pTR14, chromosomal
DNA of 
 
B. henselae
 
 Marseille was isolated with QIAGEN Ge-
nomic-tip 100/G columns and digested with EcoRI and ClaI,
yielding a 13.2-kb fragment containing 
 
badA
 
, including its puta-
tive promoter region according to the sequence of 
 
B. henselae
 
Houston-1. Fragments larger than 11 kb were ligated into pBlue-
script II KS and electroporated into E. coli TOP 10. The resulting
colonies were screened for badA by colony blotting using a
digoxigenin-labeled badA probe (primers: badA-f2 and badA-r2;
annealing at 56 C for 30 cycles). Insertion of the 13.2-kb frag-
ment in detected clones was confirmed by sequencing (primers:
M13f and M13r; not depicted). The plasmid pTR14 was digested
with BamHI and ClaI, and the insert (containing badA and the
putative promoter region) was ligated into the broad host range
vector pBBR1MCS. The resulting plasmid pTR15 was elec-
troporated in B. henselae BadA .
DNA Sequencing Procedures and DNA Sequence Analysis. Parts
of the badA sequence from B. henselae Marseille were obtained by
chromosomal sequencing as described previously (23). Additional
parts of the sequence were obtained by sequencing of cosmid clones.
Clones harboring badA were detected from a cosmid library (Super-
Cos 1 Cosmid Vector Kit; Stratagene) of B. henselae Marseille by col-
ony blotting using a badA probe (primers: badA-f2 and badA-r2).
The organization of the genomic region of badA was examined
by PCR in B. henselae Marseille WT and B. henselae Pil . Unique
PCR primers were designed using the sequence of the homologous
region in the Houston-1 strain (sequence data are available from
GenBank/EMBL/DDBJ under accession no. NC_005956) as a
template (24). PCR products were sequenced (except the highly re-
petitive inner parts of badA) using internal primers and ET termina-
tor chemistry (Amersham Biosciences). Sequences were separated
using a MEGABASE sequenator (Amersham Biosciences). Gen-
Bank accession numbers are as follows: B. henselae Marseille WT,
AY560658 (5  region) and AY560659 (3  region). The BLAST pro-
gram of the NCBI (blastn, blastx; http://www.ncbi.nlm.nih.gov)
was used to perform sequence similarity searches.
Protein Sequence Analysis. Sequence similarity searches were
performed using the programs Blast and PSI-Blast on the nonre-
dundant and microbial genomes databases at the NCBI (http://
www.ncbi.nlm.nih.gov). Sequence alignments were made in
MACAW (25). Coiled coil segments were predicted using the
program COILS (26) and a consensus method based on COILS
(unpublished data). Secondary structure predictions were made
with PSIPRED (27).
Cloning, Expression, and Purification of a BadA Stalk Fragment.
A 480-bp fragment of badA encoding for amino acid residues
377–539 (stalk region) was amplified (primers: badA-f6 and
badA-r6). The 5   primer contained an NdeI site and a start
codon, and the 3  primer contained a stop-codon followed by an
XhoI site. The fragment was cloned into the expression vector
pET30b (Novagen) giving plasmid pTR52. After transformation
into E. coli BL21 (DE3), expression was induced with 1 mM iso-
propyl  -d thiogalactopyranoside for 4 h. Cells were lysed in a
French press in 30 mM Tris-HCl, pH 7.4, 50 mM NaCl, 5 mM
dithiothreitol, 50  g/ml DNase I, and 1 mM PMSF, and the
Table II. Plasmids, Primers, and Probes Used in This Study
Plasmids Description Reference or source
pBluescript II KS cloning vector, Apr Stratagene
pET30b protein expression vector, Kmr Novagen
pBBR1MCS broad host range, Cmr 46
pTR14 pBluescript II KS containing a 13.2-kb B. henselae Marseille
EcoRI/ClaI fragment with badA, Apr This study
pTR15 pBBR1MCS containing a 13.2-kb BamHI/ClaI
fragment of pTR14 with badA, Cmr This study
pTR52 pET30b containing badA-f6/r6-PCR fragment This study
Primers
badA-f2 CTCCAGTCTGATGATTCAGC This study
badA-r2 GCTATATTGATTTCAGTACCTGC This study
badA-f6 TGCACATATGAAAGCATTAAGGGGAATGATATCAGa This study
badA-r6 TTATCTCGAGTCAAGTACGCTTATCACTTTTGTTATTAGCb This study
Probe
pilin GNTTYTTNAARGAYGARTCNGGNGCANCNGCNATHGARTAYG
GNCTNATHGCNGCNTTNATHTCNGT
This study
aItalic, NdeI restriction site.
bItalic, XhoI restriction site; underline, stop codon.BadA Mediates a Proangiogenic Host Cell Response 1270
protein was purified to homogeneity from the high speed centrif-
ugation supernatant of the lysate by a combination of cation-
exchange (MonoS HR; Amersham Biosciences; elution condi-
tions are as follows: 30 mM Tris-maleate, pH 6.0, 5 mM MgCl2,
5 mM dithiothreitol, 0–1 M NaCl gradient) and gel-sizing chro-
matography (Superdex G-75; Amersham Biosciences; in 50 mM
potassium phosphate buffer, pH 7.3, 150 mM NaCl).
Culture and Infection of ECs, J774 Macrophages, and HeLa and
GD25 Cells. Human umbilical vein ECs were cultured in EC
growth medium (PromoCell). Infection experiments were per-
formed in EC basal medium (PromoCell) as described previously
(11). The mouse macrophage cell line J774A.1 (American Type
Culture Collection [ATCC] TIB-67) was cultured in RPMI 1640
medium with 10% FCS, 2 mM l-glutamine, 1 mM sodium pyru-
vate,  -mercaptoethanol, and nonessential amino acids. Macro-
phages were seeded in 24-well tissue culture plates. HeLa cells
were grown in RPMI 1640 with 10% FCS and for infection ex-
periments, media were removed 2 h before infection and replaced
by culture media without antibiotics and FCS to avoid unspecific
HIF-1 activation.  1 integrin–deficient murine GD25 cells (28)
and  1 integrin–overexpressing GD25- 1A cells (29) were culti-
vated in DMEM (GIBCO BRL) with 10% FCS. For GD25- 1A,
10  g/ml puromycin (Sigma-Aldrich) was added. In some exper-
iments, B. henselae WT and GD25- 1A were preincubated with
an anti-fibronectin (Fn) antibody (DakoCytomation).
Bacteria were used at a multiplicity of infection of 100 and
sedimented onto cultured cells by centrifugation for 5 min at 300 g.
The actual inoculum for each experiment was determined by
plating serial dilutions and calculating the number of CFUs. For
J774 cells, intracellular bacteria were quantified 3 h after infection
by gentamicin kill assays as described previously (11).
Determination of B. henselae Binding to ECM Proteins. To assess
binding of B. henselae to ECM proteins, coverslips were coated
with 10  g/ml human collagen type I, type III (Chemicon), and
type IV (Calbiochem), and laminin (Chemicon) and Fn (Sigma-
Aldrich). After washing with PBS, 107 bacteria were resuspended
in 1 ml RPMI 1640 and sedimented on coverslips. After 1 h, cov-
erslips were washed twice with RPMI, fixed with 3.75% PBS-
buffered paraformaldehyde (PFA), and bacteria were stained with 1
 g/ml DAPI for 10 min. Adherence was determined via confocal
laser scanning microscopy (CLSM) and by counting 20 randomly
selected high power fields (1,000-fold magnification).
For detection of Fn binding by Western blotting, bacteria
were harvested in PBS and the OD550 was adjusted to 1.0. Bacte-
ria were lysed in SDS sample buffer and separated by 12% SDS-
PAGE. Membranes were incubated with a monoclonal anti-Fn
antibody (Becton Dickinson). Purified human plasma Fn (Chemi-
con) was used as a positive control (not depicted).
Detection of VEGF, IL-8, Insulin-like Growth Factor Binding Pro-
tein 3 (IGFBP-3), and Adrenomedullin (ADM) in Cell Culture Su-
pernatants. Determination of VEGF, IL-8, IGFBP-3, and ADM
secretion upon B. henselae infection was performed without anti-
biotics and FCS. 25 ng/ml PMA (Sigma-Aldrich) was used as a
positive control (not depicted; reference 7). VEGF concentration
in culture medium was measured using a human VEGF165-ELISA
kit (R&D Systems). IL-8 was determined by ELISA as described
previously (30). Secreted IGFBP-3 was measured using a specific
RIA (31) and secreted ADM was quantified by a commercially
available RIA (Phoenix Pharmaceuticals).
Detection of HIF-1  Activation. For reporter gene assays, a
VEGF promoter luciferase reporter construct (pVEGF.4) was used
(32). Transfection efficiency was normalized by cotransfection
with pCMV  -galactosidase (pCMV  -gal; CLONTECH Labo-
ratories, Inc.). 105 HeLa cells were transiently transfected with 0.5
 g pVEGF.4 Luc reporter construct and 0.25  g pCMV  -gal
using ExGen500 transfection reagent (Fermentas), and incubated
for 24 h at 37 C. Transfected cells were infected with B. henselae
or exposed to hypoxia. After 36 h, cells were lysed for determina-
tion of Luc activity, protein quantification, and measurement of
 -gal using a Luciferase Reporter Gene Assay (Roche). Lumines-
cence was measured with a Topcount scintillation counter (Pack-
ard Instrument Co.). Levels of Luc expression were normalized to
 -gal activity and total protein concentration (30). Every experi-
ment was performed in quadruplicate. The degree of induction
was determined as the ratio of Luc activity of B. henselae–infected
or hypoxia-exposed cells to that of uninfected control cells.
Immunostaining and CLSM. Bacteria were resuspended in
PBS, dried on glass slides, and fixed in 3.75% PBS-buffered PFA.
105 ECs were seeded onto coverslips and infection was stopped
by 3.75% PFA. Immunostaining of B. henselae was performed as
described previously (11) using a BadA-specific rabbit antiserum
or mouse polyclonal antibodies raised against B. henselae Mar-
seille. FITC-conjugated secondary antibodies and TRITC-labeled
phalloidin were purchased from Dianova and Sigma-Aldrich.
Bacteria were stained with DAPI. Cellular fluorescence was eval-
uated using a Leica DM IRE 2 CLSM. Three different fluoro-
chromes were detected representing the green (FITC), red (TRITC),
and blue (DAPI) channels. Images were digitally processed with
Photoshop 6.0 (Adobe Systems). Adherence to ECs and GD25
cells was quantified by counting adherent bacteria from 20 ran-
domly selected cells.
Transmission electron microscopy (TEM) and immunoelectronmicros-
copy (IEM). TEM was performed as described previously (11).
In brief, B. henselae cell pellets were fixed and after embedding in
glycide ether, the blocks were cut using an ultra microtome (Ul-
tracut; Reichert). 80-nm ultra-thin sections were stained (Ul-
trastainer; Leica) with 0.5% uranyl acetate for 10 min at 30 C and
2.7% lead citrate for 5 min at 20 C. For IEM of BadA, post-
embedding immunogold labeling was performed. Cells were
fixed and after centrifugation, the sediment was embedded in 3%
agarose at 37 C and then cooled on ice. Small parts of the agarose
blocks were embedded in Lowicryl (Polysciences Ltd.). 50-nm
ultra-thin sections were mounted on formvar-coated nickel grids
and incubated with anti-BadA rabbit serum, followed by 10 nm
gold-conjugated goat anti–rabbit IgG (Auroprobe EM; Amer-
sham Biosciences). In control samples, the primary antibody was
omitted. Grids were counterstained with uranyl acetate and lead
citrate and examined using a transmission electron microscope
(Zeiss EM 109; Carl Zeiss MicroImaging, Inc.).
Statistical Analysis. All experiments were performed at least
three times and revealed comparable results. Differences between
mean values of experimental and control groups were analyzed
by student’s t test. A p-value of  0.05 was considered statistically
significant.
Online Supplemental Material. In Fig. S1, BadA is shown in
more detail by electron microscopy (negative staining). In Fig.
S2, BadA immunoreactivity of sera from patients suffering from
CSD is evaluated by Western blotting of whole cell bacterial ly-
sates. Figs. S1 and S2 are available at http://www.jem.org/cgi/
content/full/jem.20040500/DC1.
Results
B. henselae WT, But Not B. henselae Pil  Phase Variant,
Binds Fn. To analyze the protein composition of the “pi-
lus”-like structures of B. henselae, a comparative proteinRiess et al. 1271
analysis of both B. henselae WT and a spontaneous B. hense-
lae Pil  variant was performed. TEM revealed no pilus ex-
pression of the variant strain (Fig. 1, a and b; reference 7).
Expression of “pili” correlated with the observation that
bacterial colonies of the WT stuck more tightly to the sur-
face of CBA than Pil . Protein patterns of whole bacterial
lysates (WT and Pil ) showed two high molecular weight
(HMW) proteins in B. henselae WT ( 220 kD) not present
in Pil  (Fig. 1 c). Using electrospray ionization-mass spec-
trometry/mass spectrometry, the lower band was identified
as Fn (not depicted). Analysis of the upper band revealed
four peptide fragments (ATN(I/L)(I/L)T(I/L)GK; (I/L)TY
(I/L)(I/L)F; AAVT(I/L); and (I/L)YS(I/L)NE(Q/K)(I/L)
ATYFG), which matched no entry in the database (blastp;
http://www.ncbi.nlm.nih.gov). These were later identified
as fragments of BadA (see below). We hypothesized that B.
henselae WT, but not Pil , might bind to Fn present in
CBA. To further elucidate this hypothesis, Fn binding of
B. henselae was assessed by Western blotting of whole bac-
terial lysates and detection of Fn using anti-Fn antibodies.
Fn bound to bacteria was detectable in WT, but not in Pil 
lysates (Fig. 1, d and e, lanes 1 and 2). Taken together, the
results provide evidence that expression of pilus-like struc-
tures on the surface of B. henselae is associated with binding
to Fn.
Transposon Insertion in badA Results in Loss of Fn Binding.
To identify the gene(s) coding for the putative type IV pi-
lus, a transposon library of B. henselae Marseille (23) was
screened, revealing one transposon mutant (Fig. 1 e, lane 4)
deficient in Fn binding, similar to the Pil  variant described
above. By chromosomal sequencing, the site of transposon
insertion (nucleotide position 3438) was identified as a 9.3-
kb gene of unknown function, based on the genomic se-
quence of B. henselae Houston-1 (24). Database searches re-
vealed protein sequence similarities to hypothetical genes
of yet unknown functions in Brucella melitensis, Sinorhizo-
bium meliloti, and Mesorhizobium loti (not depicted). Analysis
of the deduced amino acid sequence revealed a protein
with a calculated mass of 340 kD, consistent with the size
of the differentially expressed upper HMW protein of B.
henselae WT (Fig. 1 c). The four unidentified peptide frag-
ments mentioned above were present in this translated pro-
tein sequence. Protein sequence analysis indicated that this
protein belongs to a novel class of nonfimbrial adhesins ex-
emplified by Yersinia adhesin A (YadA; reference 16) and
Neisseria adhesin A (NadA; reference 17). Therefore, we
designated the protein Bartonella adhesin A (BadA).
BadA Has a Modular Structure and Belongs to the Class of
Nonfimbrial Adhesins. BadA shows a high degree of mod-
ularity in its domain structure. After a putative signal se-
quence and a region not similar to any other currently
known protein (Fig. 2 a), BadA contains 11 degenerate 14-
residue repeats resembling those found in the YadA head
sequence (16), which form a novel-type of left-handed
 -helix (33). Two of these repeats are interrupted by se-
quence inserts. At the COOH terminus, after a motif that
is highly conserved (often in multiple copies in most non-
fimbrial adhesins [16], termed a “neck sequence”), BadA
again resembles YadA in the succession of a right-handed
coiled coil segment with pentadecad periodicity, a left-
handed coiled coil segment with heptad periodicity, and a
membrane anchor domain containing four transmembrane
  strands. The membrane anchor is thought to form a 12-
stranded pore upon trimerization and allow the autotrans-
port of the adhesin across the outer membrane (34). It is
conserved in all nonfimbrial adhesins and may represent
their defining feature. In between these two N- and
COOH-terminal YadA-like regions, BadA contains a sin-
gle occurrence of a sequence found repetitively in proteins
of Xylella spp., followed by 21 occasionally truncated cop-
ies of a sequence also seen in putative adhesins from uro-
pathogenic and enterohaemorrhagic E. coli, Shigella flexneri,
and  Salmonella spp. (Fig. 2 b). These central repeats of
BadA contain left-handed coiled coil segments and are sep-
arated by neck sequences (24 in total). This is the highest
number observed in any protein so far. Structurally, the
fairly regular alternation of coiled coil and globular se-
quences suggests an extended, rod-like shape with periodi-
cally recurring bulkier and thinner parts, rather like a seg-
mented rope. This conjecture fits well with the great
estimated length of BadA ( 100–300 nm), as well as its
hair-like, flexible appearance in electron micrographs (Fig.
1 a and Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20040500/DC1).
Genomic Organization of the badA Region. The upstream
region of the badA gene (B. henselae Houston-1; gene
BH01510) contains three short open reading frames, one of
which (BH01500) shows sequence similarity to the 3  end
of badA, thought to encode the membrane anchor region
(Fig. 2 c). Further upstream is another open reading frame
(BH01490) that displays sequence similarity with badA
Figure 1. Phase variation of B. henselae. (a and b) Expression of so-
called type IV-like pili (BadA, arrow; see also Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20040500/DC1) of B. henselae Marseille
WT not detectable on the surface of B. henselae Pil . (c) SDS-PAGE of B.
henselae WT and Pil  showing two differential HMW bands. The lower band
is Fn (240 kD), the upper is BadA (calculated mass: 340 kD). (d) Detection of
Fn binding of B. henselae WT and Pil  by Western blotting. Bacteria-
bound Fn was detected using an anti-Fn antibody. (e) Screening of a B.
henselae transposon library for Fn binding. B. henselae WT (lane 1), Pil 
(lane 2), and transposon mutants (lanes 3–10). Fn binding is not detectable
in B. henselae Pil  and in a transposon mutant (lane 4), suggesting loss of
BadA (pilus) expression.BadA Mediates a Proangiogenic Host Cell Response 1272
(47% over aligned amino acid regions) and also encodes an
anchor region. A PCR-based survey revealed an identical
gene organization pattern in B. henselae Marseille WT. A
similar survey of B. henselae Marseille Pil  revealed a large
deletion of 8.5 kb spanning from the 5  terminal end of
BH01490 to the 5  terminal end of badA. The deletion
seems to have been mediated by repeated sequences present
in the beginning of BH01490 and badA, resulting in the
loss of most of BH01490, the 5  terminal end of badA, and
the intergenic segment flanked by these two genes. As a
consequence, the 5  terminal end of BH01490 has fused
with a truncated version of badA in the Marseille Pil 
strain. Additionally, in the Houston-1 strain there is a 1-bp
deletion at the anchor region of badA that is not detected in
the Marseille strain. As a consequence, the anchor region is
not located inside BH01510, but in a separate small gene
(BH01520) that is partially overlapping with the 3  termi-
nal end of BH01510 in the Houston-1 strain. In contrast,
Figure 2. Protein domain structure of BadA and genomic organization of badA region. (a) Sequence representation and (b) schematic diagram of the
BadA domain structure. Individual domains are color coded. For simplicity, the colors are explained in the figure itself. Regions that could not be
assigned by sequence similarity are left black in (a) and shown as open boxes in (b). The sequence is BadA of B. henselae Houston-1. Regions also
sequenced in B. henselae Marseille are marked by black bars in (a) and residues different in the two strains are shown staggered, with the Houston-1
sequence above and the Marseille sequence below. In (b), structurally equivalent regions are connected by gray bars. The organisms are as follows:
Bh, B. henselae; EcCFT073, E. coli strain CFT073; StLT2, Salmonella typhimurium strain LT2; Ye, Y. enterocolitica. (c) Schematic diagram of the arrange-
ment of genes in a 17.7-kb genomic region of B. henselae Houston-1. Details are given in Results. Site of transposon insertion in B. henselae Marseille
BadA  and position of the frameshift in the membrane anchor region of B. henselae Houston-1 are indicated. Loss of BadA (pilus) expression in a sponta-
neous B. henselae Marseille variant (B. henselae Pil ) is correlated with an 8.5-kb deletion (arrow).
Figure 3. BadA expression of B. henselae Houston-1 (ATCC 49882)
and B. henselae Marseille. (a) BadA expression was analyzed by immunofluo-
rescence and Western blotting using an anti-BadA rabbit serum (arrow). Bar,
2  m. (b) Detection of BadA expression by TEM. BadA is expressed on
the surface of B. henselae Marseille (arrow), but missing in the Houston-1
strain (ATCC 49882).Riess et al. 1273
BH01510 and BH01520 are merged into a single gene in
the Marseille strain. BadA is expressed in B. henselae
Marseille, but not in Houston-1 (Fig. 3). From this data we
conclude that the B. henselae Houston-1 strain we investi-
gated (ATCC 49882) lacks BadA expression.
Complementation of B. henselae BadA  Reveals That BadA
Forms the Pilus-like Structure. Complementation of the
BadA  mutant was performed with plasmid pTR15 con-
taining a 13.2-kb chromosomal fragment carrying WT
badA, including its putative promoter region. TEM re-
vealed that expression of BadA in B. henselae BadA /
BadA  WT leads to the formation of the pilus-like struc-
ture (Fig. 4 a). An anti-BadA rabbit serum generated by
immunization with a BadA stalk fragment revealed a strong
surface staining of the WT and the complemented mutant
not detectable in Pil  and BadA  (Fig. 4 b). Consistent data
were obtained by IEM showing clearly that BadA is stained
(Fig. 4 c). In accordance, this serum was reactive against
BadA in OMP preparations of B. henselae WT not present
in Pil  (not depicted). These results suggest strongly that
the formerly described type IV pilus (12) is in fact the non-
fimbrial adhesin BadA.
Figure 4. Complementation of B. henselae BadA . (a) De-
tection of BadA expression in B. henselae WT, Pil ,
BadA , and BadA /BadA  WT by TEM. Note the brush-
like arrangement of BadA on the surface of the WT and
the complemented mutant (arrows) missing in the Pil 
variant and the BadA  mutant. (b) Detection of BadA ex-
pression by immunofluorescence using an anti-BadA rabbit
serum. Bar, 2  m. (c) Detection of BadA expression by
IEM using 10 nm gold-conjugated goat anti–rabbit IgG.
Figure 5. BadA-dependent interaction
of B. henselae with ECM proteins. Col-
lagen type I, III, and IV, and laminin and
Fn binding of B. henselae WT, Pil ,
BadA , and BadA /BadA  WT. (a) Bac-
teria were seeded onto coated coverslips
and DAPI stained. Bar, 20  m. Fn bind-
ing was additionally assessed by Western
blotting. (b) Microscopic quantification
of bacterial binding to ECM proteins
(adherent bacteria per high power field).
*, significant difference compared with
B. henselae WT (P   0.01).BadA Mediates a Proangiogenic Host Cell Response 1274
BadA Is Crucial for Interaction of B. henselae with ECM and
Host Cells. To investigate whether BadA is involved in
binding to ECM proteins, B. henselae was exposed to col-
lagen type I, III, and IV, and laminin- and Fn-coated cov-
erslips (Fig. 5). BadA-expressing B. henselae WT and
BadA /BadA  WT bound to a higher degree to these
ECM protein–coated surfaces than Pil  or BadA . The
ability to bind Fn was reconstituted in BadA /BadA  WT
as additionally shown by Western blotting. From this data
we conclude that expression of BadA is crucial for adher-
ence of B. henselae to ECM proteins.
Nonfimbrial adhesins mediate adherence of bacteria to
host cells (16). As one potential target in B. henselae infec-
tions is ECs (6, 10, 11), the role of BadA in adherence to
these cells was investigated. ECs were infected with B.
henselae WT, Pil , BadA , and BadA /BadA  WT and ad-
herence was assessed 30 min after infection by CLSM (Fig.
6, a and b). Both B. henselae Pil  and BadA  hardly adhered
to ECs, showing that BadA expression is crucial for host
cell adherence. Consistently, TEM suggests that BadA me-
diates adherence of B. henselae to ECs (Fig. 6 c). Next, we
analyzed the role of  1 integrins in the binding of B. hense-
lae to host cells, as they mediate YadA-dependent adher-
ence of Yersinia (35). For this purpose, the fibroblast cell
lines GD25 (lacking  1 integrins; reference 28) and GD25-
 1A (overexpressing  1 integrins; reference 29) were in-
fected with B. henselae WT. Data revealed a significantly
decreased adherence of B. henselae WT to GD25, suggest-
ing that  1 integrins act as a cellular binding partner of
BadA. This binding might be mediated by Fn, as pretreat-
ment of cells and bacteria with anti-Fn antibodies abolished
bacterial adherence to the background level (Fig. 6, d and
e). Furthermore, like YadA (36), expression of BadA pre-
vents B. henselae WT from phagocytosis in J774 murine
macrophages (Fig. 6 f).
Induction of a Proangiogenic Host Cell Response Depends on
BadA Expression. HIF-1 is the key transcription factor of
angiogenesis regulating, e.g., VEGF, IGFBP-3, and ADM
(9). As a B. henselae infection activates HIF-1 in host cells
(epithelial and endothelial) in vitro and in BA lesions in
vivo (unpublished data), we elucidated the role of BadA in
this process (Fig. 7 a). HeLa cells were transiently trans-
fected with a VEGF promoter luciferase reporter construct
(pVEGF.4; reference 32) specifically regulated by HIF-1.
Figure 6. BadA mediates cell adherence and shares an-
tiphagocytic properties. (a) Adherence of B. henselae WT,
Pil , BadA , and BadA /BadA  WT to ECs shown by
CLSM. Bacteria were labeled by FITC-conjugated anti-
bodies (green signal) and filamentous actin was stained
with TRITC-labeled phalloidin (red signal). Bar, 20  m.
(b) Microscopic quantification (bacteria/cell) of EC ad-
herence. (c) Adherence of B. henselae WT to ECs shown
by TEM. Note that adherence of B. henselae WT to the cell
surface is mediated via BadA (arrow). (d) Adherence of B.
henselae WT to GD25 ( 1 ) and GD25  1 integrin–over-
expressing ( 1 ) fibroblasts shown by CLSM. For modula-
tion, bacteria and  1  cells were preincubated with anti-Fn
antibodies ( 1   FN). (e) Microscopic quantification of
bacterial adherence to GD25 and GD25  1 integrin  fibro-
blasts. (f) Intracellular B. henselae WT, Pil , and BadA  3 h
after infection of J774 macrophages. Bacteria (percent of
inoculum) were calculated from gentamicin protection assays.
(g) Interaction of B. henselae WT with J774 macrophages
shown by TEM. Note that adherence of B. henselae WT to
the cell surface is mediated via BadA (arrow). *, Significant
difference compared with B. henselae WT (P   0.01).Riess et al. 1275
Infection with B. henselae WT resulted in a 3.3-fold in-
crease in HIF-1–regulated VEGF gene transcription (posi-
tive control: hypoxia, 13.2-fold stimulation). Both B. hense-
lae Pil  (1.1-fold) and BadA  (1.1-fold) did not activate
the VEGF promoter in contrast to BadA /BadA  WT
(4.9-fold). Consistently, secretion of VEGF was fully in-
duced by BadA /BadA  WT (Fig. 7 b). Next, the role of
BadA in mediating an angiogenic host cell response was in-
vestigated. HeLa cells were infected with B. henselae WT
and BadA , and secretion of VEGF, ADM, IGFBP-3, and
IL-8 was assessed over 72 h (Fig. 7 c). Infection with B.
henselae WT led to a strong induction of these cytokines,
whereas BadA  failed to induce any of these. From these
data we conclude that expression of BadA by B. henselae is
crucial for the activation of HIF-1 and has major impor-
tance in the proangiogenic reprogramming of host cells.
BadA Is an Immunodominant Surface Molecule in B. hense-
lae–infected Patients and Rodents. It has been shown that
NadA leads to an anti-NadA immune response in mice (17).
Therefore, we were interested in the immunological prop-
erties of BadA in B. henselae infections (Fig. 8 and Fig. S2).
Serum of 7 out of 11 patients suffering from a clinically di-
agnosed and serologically confirmed CSD (IgG reactivity in
immunofluorescence test: 1:200) showed a strong reactivity
to BadA identified by Western blots. The BadA-specific
bands were absent in B. henselae Pil  (not depicted) and
BadA . The same results were obtained with the serum of a
rabbit infected with viable B. henselae WT. Anti-BadA reac-
tivity was also seen in sera of mice immunized with heat-killed
B. henselae. These results suggest that (a) BadA is ex-
pressed in vivo in patients suffering from Bartonella infec-
tions, (b) BadA-specific antibodies are produced in the
course of CSD, and (c) that BadA might be a diagnostic
marker for the serological diagnosis of B. henselae infections.
Discussion
Besides pili, nonpilus-associated adhesins, which are
monomeric or oligomeric proteins anchored to the outer
membrane, are important bacterial pathogenicity factors.
The nonfimbrial adhesins, e.g., YadA of enteropathogenic
Yersinia species and NadA of N. meningitidis represent a
novel class of adhesins widely distributed in proteobacteria
(16, 17).
BadA Represents a Novel Nonfimbrial Adhesin of B. henselae.
The large, filamentous surface structures of B. henselae were
formerly called type IV pili based on phenotypic and func-
tional properties (adhesion to host cells, autoagglutination;
reference 12). Serial passage in vitro leads to a loss of pilus
expression in B. henselae. However, we have not been able
to detect pilin genes in B. henselae Marseille using a degen-
erated probe (Table II) for Southern blotting deduced
from pilA of Caulobacter crescentus (sequence data are avail-
Figure 7. BadA-dependent HIF-1 activation
and secretion of proangiogenic cytokines. (a)
HIF-1 activation detected by the use of a
VEGF promoter luciferase reporter construct
(pVEGF.4). HeLa cells were transfected before
infection with B. henselae WT, Pil , BadA ,
and BadA /BadA  WT. Activation was deter-
mined by chemiluminescence 36 h after infec-
tion. (b) Induction of VEGF secretion upon in-
fection of HeLa cells. Supernatants were taken
48 h after infection and analyzed by ELISA. (c)
BadA-dependent secretion of proangiogenic
cytokines in Hela cells. Cells were infected with
B. henselae WT and BadA , and the amount of
secreted VEGF, IGFBP-3, ADM, and IL-8 was
determined 8, 24, 48, and 72 h after infection
by ELISA or RIA. *, significant difference
compared with uninfected control (P   0.01).
Figure 8. Immunodominance of BadA in humans, rabbits, and mice.
Western blots of whole cell lysates of B. henselae WT and BadA  were
incubated with serum of a patient suffering from CSD (see also Fig. S2),
serum of a rabbit infected with viable B. henselae, and serum of a mouse
immunized with heat-killed B. henselae. The arrow indicates BadA. Note
that antibodies against BadA are detected in each of the sera. Immunore-
activity of a specific anti-BadA rabbit serum is shown for control.BadA Mediates a Proangiogenic Host Cell Response 1276
able from GenBank/EMBL/DDBJ under accession no.
AF_229646),  Agrobacterium tumefaciens (accession no.
AE_007963), S. meliloti (accession no. AL_591782), and M.
loti (accession no. NP_104554; not depicted). Moreover,
no pilin genes were found in the B. henselae Houston-1 ge-
nome sequence (24).
We show that a transposon mutant deficient in expres-
sion of the 340-kD BadA was complemented by badA (9.3
kb) cloned with its putative promoter region. Our investi-
gations revealed that the so-called type IV pilus of B. hense-
lae belongs, like YadA and NadA, to a novel family of non-
fimbrial adhesins (16).
B. henselae OMPs have been suggested to be relevant for
attachment to ECs (13), induction of a proinflammatory
cell response (14), and induction of EC proliferation (5).
However, the presence of BadA was not indicated in any
of these reports. Reasons for the lack of BadA in the pub-
lished OMP patterns might be explained by difficulties in
gel electrophoresis due to protein size (340 kD) or loss of
BadA expression due to extensive passaging and phase vari-
ation (7, 12).
Most data on the pathogenicity of B. henselae have been
obtained using bacteria of variable and unstated passage
number. The identification of a deletion mutation in the
published genome sequence of the Houston-1 strain and
the high density of repeated sequences within the badA
gene and BH01490, which provides targets for recombina-
tion and deletion events, suggests that a high level of vari-
ability in sequence and expression among strains is to be
expected. Therefore, we recommend that expression of
BadA should be evaluated when performing infection ex-
periments with B. henselae.
BadA Is an Unusual Representative of the Nonfimbrial Adhe-
sins. Nonfimbrial adhesins share a common architecture,
consisting of a head, a stalk, and a membrane anchor (16).
This architecture is reflected in a number of broadly occur-
ring sequence motifs, most notably the degenerate 14-resi-
due head repeats, which have been shown in YadA to form
a left-handed  -helix (33), the neck sequence, which in
YadA separates the head from the stalk and forms a novel
trimerization motif (33), and the membrane anchor region,
consisting of four transmembrane   strands with potential
pore-forming and autotransporter properties (34). All of
these motifs are also found in BadA, showing that this pro-
tein is a canonical nonfimbrial adhesin. BadA, however,
contains additional sequence motifs that have not, so far,
been described. Strikingly, these motifs have their closest
matches in proteins from   proteobacteria (Xylella, Esche-
richia, Shigella, and Salmonella), whereas B. henselae belongs
to the   proteobacteria, suggesting an active “trade” in ad-
hesion domains between phylogenetically distant bacteria.
Most conspicuous are segments of  100 residues, which
occur in 21 partly truncated copies in the center of the
molecule and are separated from each other by neck se-
quences. These segments, which contain interspersed coiled
coil sequences, account for the surprising size of BadA and
probably represent a novel type of stalk architecture judg-
ing from electron micrographs. Sequence similarity leads us
to expect that similar adhesins will be found on the surface
of uropathogenic and enterohaemorrhagic E. coli as well as
of Salmonella spp.
The Role of BadA in the Infection Process. Collagen bind-
ing of Y. enterocolitica depends on the head repeats of YadA
(37). Similar repeats are also present in the BadA head do-
main and it might be speculated that these motifs mediate
adhesion of B. henselae to ECM proteins of the basal mem-
brane of blood vessels, which mainly consist of collagen IV
and laminin (38), facilitating subsequent infection of ECs.
In accordance, adherence of B. henselae to collagen type I,
III, and IV depends on BadA expression. The molecular
basis of the laminin- and Fn-binding capacity of BadA re-
mains unclear. Like YadA (36), BadA shares antiphagocytic
capacities, as expression of BadA prevents B. henselae from
phagocytosis in J774 murine macrophages.
Our data clearly show that expression of BadA is impor-
tant for adherence of B. henselae to ECs that represent one
potential habitat (10, 11). It is known that Fn-binding pro-
teins, such as those of N. meningitidis, promote the infection
process of host cells, possibly via Fn bridging to  5 1 inte-
grins (39). Using  1 integrin–overexpressing GD25 cells
and anti-Fn antibodies, we demonstrated that  1 integrins
are crucial for cell adhesion of B. henselae, possibly via Fn
bridging. Our data are also in line with previous reports
(35) that show that  1 integrins are required for YadA
binding to host cells.
The Role of BadA in the Induction of a Proangiogenic Host
Cell Response. HIF-1 is the key transcription factor in an-
giogenesis (9). Of the many genes induced by HIF, VEGF
represents the major mitogen for ECs (40). We and others
demonstrated that a B. henselae infection results in host cell
VEGF secretion in vitro and in BA and BP in vivo (7, 8).
Moreover, HIF-1 is activated in host cells by B. henselae in
vitro and in BA lesions in vivo, and VEGF, IGFBP-3,
ADM, and IL-8 (all sharing angiogenic capacities; references
41–43) are secreted in vitro (unpublished data). Our data
show that expression of BadA is crucial for both HIF-1 acti-
vation and secretion of proangiogenic compounds. There-
fore, BadA appears to play a crucial role in the induction of
a proangiogenic host cell response. Whether BadA directly
triggers expression of proangiogenic factors or mediates ad-
hesion of B. henselae to host cells followed by subsequent
pathogen–host cell interactions, is not yet clear. Binding of
Fn to  5 1 integrins results in activation of a proangiogenic
gene expression program (44). One could speculate that
BadA might be involved in triggering a proangiogenic host
cell response via Fn bridging to  5 1 integrins.
Immunodominance of BadA. Sera of patients suffering
from Bartonella infection and of rabbits infected with viable
B. henselae reacted with BadA in immunoblotting (Fig. 8
and Fig. S2), suggesting that BadA is expressed in B. hense-
lae infections. The biological functions of BadA expression
in vivo might be to avoid phagocytosis similar to YadA
(36) and to adhere to ECs. Antibodies against YadA and
NadA mediate protection in Y. enterocolitica and N. menin-
gitidis infections (17, 45). For vaccination strategies against
zoonotic  Bartonella in their mammalian reservoirs, BadARiess et al. 1277
could therefore be a promising vaccine candidate. The im-
munodominance of BadA in the sera of B. henselae–infected
patients suggests also that it might be a suitable marker for
serodiagnosis of B. henselae infections.
In conclusion, the nonfimbrial adhesin BadA is (a) an
unusual modularly constructed, surface-exposed HMW pro-
tein, (b) highly important for pathogen–host cell interac-
tions, (c) involved in the induction of a proangiogenic host
cell response, and (d) an immunodominant antigen. Fur-
ther investigations will elucidate the role of this multifunc-
tional molecule in Bartonella infections.
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